Biotechnology company ZymoGenetics Inc. said Thursday it is publicly offering about $79 million in common stock and boosting the number of shares, increasing the number it said it would offer.
51501
ZymoGenetics offering $79 million in common stock
98304
Drug stocks climb;
133059
Investment pays off for Cyprotex
47838
Stock dividends rising rapidly
36904
Novia adds to discretionary offering
60565
Orexigen Therapeutics Inc reports grant of inducement stock option
78827
Options trading heats up in Amgen
31123
NYSEG requests rate hike
23688
Ford raises $1.4 billion from share offer
24994
Pluristem Therapeutics to present at the Tel-Aviv Stock Exchange
104931
Drug stocks retrench with broad market;
92657
Roche boosts offer for Genentech
125870
BLOMINVEST raises target for Holcim share
127668
Javelin Pharmaceuticals, Inc. comments on tender offer extension by Hospira
97802
Viterra to raise $400 million in offering of common shares to fund growth
17783
Public shareholdings spread
55594
Juvaris BioTherapeutics raises $25 million